Indevus/Pliva Sanctura For Overactive Bladder Clears FDA; Third Quarter Launch Planned

Indevus and Pliva will detail trospium with a sales force of approximately 480 reps under a co-promotion deal signed in April. The companies will face marketing powerhouses Pfizer (Detrol LA) and J&J (Ditropan XL).